Education
About Us
Working with TipRanks
Follow Us
Alkermes (ALKS)
NASDAQ:ALKS
Earnings Data
Report Date
Oct 22, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.4Last Year’s EPS
0.72Same Quarter Last Year
Moderate Buy
Based on 13 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook for Alkermes, with strong financial results, successful clinical trial outcomes, and a robust cash position. However, increased R&D expenses and variability in cataplexy endpoint results present challenges.Company Guidance
Strong Financial Performance
Alkermes reported total revenues of $390.7 million for the second quarter, with net sales of proprietary products reaching $307.2 million, reflecting a 14% year-over-year growth. The company also achieved GAAP net income of $87.1 million and adjusted EBITDA of $126.5 million.
Successful Phase II Study for Alixorexton
Positive top-line results were reported from the Vibrance 1 Phase II study of alixorexton in patients with narcolepsy type 1, showing significant effects on wakefulness and improvements in fatigue and cognition.
Strong Cash Position
The company ended the quarter with $1.05 billion in cash and total investments, providing significant optionality for future growth.
Growth in Proprietary Product Portfolio
VIVITROL, ARISTADA, and LYBALVI showed strong year-over-year growth, with VIVITROL net sales reaching $121.7 million and LYBALVI net sales growing 18% year-over-year to $84.3 million.
ALKS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ALKS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 29, 2025 | $26.15 | $27.00 | +3.25% |
May 01, 2025 | $28.77 | $30.58 | +6.29% |
Feb 12, 2025 | $31.96 | $33.50 | +4.82% |
Oct 24, 2024 | $27.85 | $26.85 | -3.59% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Alkermes (ALKS) report earnings?
Alkermes (ALKS) is schdueled to report earning on Oct 22, 2025, Before Open (Confirmed).
What is Alkermes (ALKS) earnings time?
Alkermes (ALKS) earnings time is at Oct 22, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ALKS EPS forecast?
ALKS EPS forecast for the fiscal quarter 2025 (Q3) is 0.4.